Check out the companies making headlines in extended trading. Palantir Technologies — Shares dropped nearly 7% after the defense tech company reported first-quarter earnings that were in line with Wall Street’s expectations. Adjusted earnings of 13 cents per share came in-line with the consensus estimate, per LSEG. Palantir reported $884 million in revenue, topping the $863 million forecast by analysts. Vertex Pharmaceuticals — The biotech stock dropped 2% on disappointing quarterly results. Adjusted earnings came in at $4.06 per share, below the $4.32 per share forecast by analysts surveyed by LSEG. Revenue of $2.77 billion also missed analysts’ estimates for $2.85 billion. Mattel — Shares of the toymaker declined 2.5% after management paused its 2025 full-year guidance due to tariff uncertainty. Meanwhile, first-quarter results topped analysts’ estimates. Neurocrine Biosciences — The maker of neurological drugs jumped 11% postmarket after first-quarter revenue of $572.6 million topped a $559.6 million estimate from analysts surveyed by FactSet. Sales of Ingrezza, used to treat movement disorders, rose 8% year-over-year to $545 million. Lattice Semiconductor — The chip stock fell 3.8% after first-quarter earnings and revenue both were in-line with consensus estimates. Lattice guided toward current quarter revenue between $118.5 million to $128.5 million, while analysts polled by LSEG expected $123.6 million. Adjusted earnings are estimated to range from 22 cents to 26 cents per share, versus the 24 cents per share analysts were looking for. Hims & Hers Health — The telehealth company dropped 1%. Guidance for second-quarter revenue came in lighter than expected, ranging from $530 million to $550 million, while analysts polled by FactSet sought $564.6 million. Earnings and revenue for the first quarter surpassed the Street’s expectations, however. Ford Motor — The maker of F-series pickup trucks fell 2.7% after hours on first-quarter results showing earnings ex-items before interest and taxes (EBIT) plunged to $1.02 billion from $2.76 billion a year ago, according to FactSet. Ford estimated the net cost of higher tariffs on EBIT in 2025 at about $1.5 billion and withdrew forward guidance. Clorox – Shares of the cleaning products manufacturer fell 2.8%. Clorox posted adjusted earnings of $1.45 per share on revenue of $1.67 billion in the fiscal third quarter. That fell short of analysts’ call for $1.57 per share in earnings and $1.73 billion in revenue, per LSEG. Diamondback Energy – The energy stock advanced nearly 1% after reporting better-than-expected results. Diamondback earned $4.54 per share, ex-items, in the first quarter, topping FactSet consensus estimates for $4.18 per share. Cash capital expenditures of $942 million in the period was less than the $952.8 million forecast by Wall Street. — CNBC’s Darla Mercado and Scott Schnipper contributed reporting
#Stocks #making #biggest #moves #hours #Palantir #Technologies #Ford #Motor #Mattel #Clorox
Vertex Pharmaceuticals Inc,Hims & Hers Health Inc,Clorox Co,Mattel Inc,Ford Motor Co,Palantir Technologies Inc,regwall-marketmovers,Market Insider,Markets,Economy,Stock markets,Breaking News: Markets,Business,Neurocrine Biosciences Inc,Lattice Semiconductor Corp,Diamondback Energy Inc,business news
latest news today, news today, breaking news, latest news today, english news, internet news, top news, oxbig, oxbig news, oxbig news network, oxbig news today, news by oxbig, oxbig media, oxbig network, oxbig news media
HINDI NEWS
News Source
